Cleveland Clinic researchers discovered a new bacterium, Tomasiella immunophila, that breaks down SIgA and may contribute to inflammatory bowel diseases.

Cleveland Clinic researchers have identified a new bacterium, Tomasiella immunophila, which undermines gut immunity and may contribute to conditions like inflammatory bowel disease, Crohn's, and ulcerative colitis. This bacterium breaks down secretory immunoglobulin A (SIgA), a vital component of the gut's immune defense. The discovery paves the way for potential new therapies aimed at restoring SIgA levels and improving gut health.

September 26, 2024
6 Articles